MOTS-c
Mitochondrial-derived peptide (investigational) · Pre-filled pen
MOTS-c is a mitochondrially derived peptide studied for its role in cellular energy sensing. It is associated with activation of the AMPK pathway and with signalling linked to glucose uptake, insulin sensitivity and mitochondrial adaptation. Most supporting data come from preclinical and mechanistic studies rather than large human trials.
Studied use areas
- Metabolic-flexibility research
- Insulin-sensitivity and glucose-utilisation signalling
- Mitochondrial biogenesis and cellular-energy endpoints
- Exercise-adaptation and physical-performance research
Safety & status
- Investigational compound with limited human clinical data; it is not an approved medicine
- Should only be considered within physician-supervised, appropriately governed settings
- Purity, quality and long-term safety of research-grade material are not assured
- No dosing is provided; any use would be individualised and determined by the treating physician
⚕ Clinical note: This is educational information, not medical advice. MOTS-c is investigational with limited human evidence; it is not a proven treatment, and any use requires qualified physician supervision.
Evidence: Grade C — investigational, mostly preclinical and mechanistic evidence · References: Peer-reviewed mitochondrial-biology and metabolism literature; Preclinical mitochondrial-derived peptide research; Early-phase human metabolic-signalling studies
